Table A.15.2

Warning View the most recent version.

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.


Table A.15.2
Total in-house research and development (R&D) expenditures by bioproducts establishments in Canada, by establishment size, 2014 and 2015
Table summary
This table displays the results of Total in-house research and development (R&D) expenditures by bioproducts establishments in Canada. The information is grouped by Size (appearing as row headers), 2014 and 2015, calculated using $ thousands units of measure (appearing as column headers).
Size 2014 2015
$ thousands
Small (less than 50 employees)
Total In-house R&D expenditures 81,313Table A.15.2 Note D 66,983Table A.15.2 Note D
Current in-house R&D expenditures 53,738Note E: Use with caution 46,327Table A.15.2 Note D
Capital in-house R&D expenditures 27,575Note E: Use with caution 20,656Note E: Use with caution
Medium (50 to 149 employees)
Total In-house R&D expenditures 30,806Note E: Use with caution 35,040Note E: Use with caution
Current in-house R&D expenditures Note x: suppressed to meet the confidentiality requirements of the Statistics Act 31,067Note E: Use with caution
Capital in-house R&D expenditures Note x: suppressed to meet the confidentiality requirements of the Statistics Act 3,973Note E: Use with caution
Large (more than 149 employees)
Total In-house R&D expenditures 9,491Note E: Use with caution 10,109Note E: Use with caution
Current in-house R&D expenditures Note x: suppressed to meet the confidentiality requirements of the Statistics Act 9,210Note E: Use with caution
Capital in-house R&D expenditures Note x: suppressed to meet the confidentiality requirements of the Statistics Act 899Note E: Use with caution
Date modified: